A Joint Venture of Quintiles and Thermo Fisher Scientific
CENDUIT NEWS
November 28, 2011 - Cenduit Continues Expansion with Key Management HiresJanuary 26, 2012 - Cenduit Experts to Present at Clinical Trial Supply Events
January 28, 2010 - Cenduit and invivodata, inc. Align to Integrate Clinical IRT and ePRO Solutions
December 9, 2009 - Cenduit Selects SAP BusinessObjects to Revolutionize Clinical Trial Reporting & Analytics
April 23, 2008 - Executives Join Cenduit’s Team
About Cenduit, LLC
Cenduit is a privately owned joint venture of Quintiles and Fisher Clinical Services, a division of Thermo Fisher Scientific. Cenduit has successfully deployed IRT solutions in over 650 clinical studies. Cenduit’s IRT solution is currently being used in Phase I through Phase IV clinical trials by over 16,000 sites in 78 countries, to enroll more than 220,000 subjects for over 30 indications. There are currently 46 languages utilized in the Cenduit IRT platform, supporting all languages in the ISO country list.
Cenduit is dedicated to Quality, Partnership, Efficiency, and Exemplary Customer Service. Cenduit has over 200 domain specialists consisting of project management, technical, validation, programming, and quality control/assurance global staff located in Research Triangle Park, North Carolina USA, Allentown, Pennsylvania USA, Horsham, London UK, Basel, Switzerland, and Bangalore, India.
